We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Three drugmakers urged the U.S. Supreme Court not to review a lower court’s decision on the controversial patent deal between Allergan and the St. Regis Mohawk tribe. Read More
Pennsylvania’s auditor general is pushing for new state and federal legislation to increase oversight of pharmacy benefit managers and allow only flat fee rebates. Read More
Outcomes-based contracting may not help reduce drug prices, one witness cautioned lawmakers in a House Ways and Means subcommittee hearing on Thursday. Read More